Alligator Bioscience's Board of Directors reduces its fees and offers possibility for postal voting in front of the Annual General Meeting
Lund, Sweden, April 20, 2020 – Alligator Bioscience (Nasdaq Stockholm: ATORX), today announced that the company's Nomination Committee, following an initiative from all members of the Board of Directors, proposes that the fees to board-members are reduced with 20 percent compared to the Nomination Committee’s original proposal to the Annual General Meeting to be held on May 5. “In the strenuous situation created by the Covid-19 pandemic, cost reductions are important precautionary measures in all parts of the business community. With Alligator now distinctly focusing on its clinical